pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

63 catalysts · 35 grant · 15 approval · 5 device 510k · 4 device pma · 4 device recall

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 74 catalysts2026-08-11: 16 catalysts2026-08-12: 19 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 2 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 20 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 8 catalysts2026-11-03: 16 catalysts2026-11-04: 22 catalysts2026-11-05: 36 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-02-02×to 2026-02-02×clear all
type
  • grant35
  • approval15
  • device 510k5
  • device pma4
  • device recall4
therapy area

no tagged catalysts yet

Week of Feb 2, 2026

50
›Feb 2, 2026approval190d agoCONCERTA (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalJanssen Therapeutics

Sponsor: JANSSEN PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗
›Feb 2, 2026approval190d agoCONCERTA (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalJanssen Therapeutics

Sponsor: JANSSEN PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗
›Feb 2, 2026approval190d agoCONCERTA (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalJanssen Therapeutics

Sponsor: JANSSEN PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗
›Feb 2, 2026approval190d agoMETHYLENE BLUE — FDA approvalMETHYLENE BLUE

Sponsor: ZYDUS LIFESCIENCES. Form: SOLUTION. Route: INTRAVENOUS

full page →METHYLENE BLUE →fda approvals ↗
›Feb 2, 2026approval190d agoTYRUKO (NATALIZUMAB-SZTN) — FDA approvalnatalizumab biosimilar

Sponsor: SANDOZ INC. Form: INJECTABLE. Route: INJECTION

full page →natalizumab biosimilar →fda approvals ↗
›Feb 2, 2026approval190d agoLENALIDOMIDE — FDA approvalLENALIDOMIDE

Sponsor: CIPLA. Form: CAPSULE. Route: ORAL

full page →LENALIDOMIDE →fda approvals ↗
›Feb 2, 2026approval190d agoPRIMAQUINE (PRIMAQUINE PHOSPHATE) — FDA approvalprimaquine phosphate

Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL

full page →primaquine phosphate →fda approvals ↗
›Feb 2, 2026approval190d agoNORLIQVA (AMLODIPINE BESYLATE) — FDA approvalChina Resources Saike Pharmaceutical Co Ltd

Sponsor: CMP DEV LLC. Form: SOLUTION. Route: ORAL

full page →fda approvals ↗
›Feb 2, 2026approval190d agoAIR — FDA approval

Sponsor: GENERAL AIR SERVICE & SUPPLY COMPANY. Form: GAS. Route: INHALATION

full page →fda approvals ↗
›Feb 2, 2026approval190d agoPUR-WASH (PURIFIED WATER) — FDA approval

Sponsor: NIAGARA PHARMS. Form: SOLUTION. Route: OPHTHALMIC

full page →fda approvals ↗
›Feb 2, 2026approval190d agoFIDAXOMICIN — FDA approvalDificid

Sponsor: APOTEX. Form: TABLET. Route: ORAL

full page →Dificid →fda approvals ↗
›Feb 2, 2026approval190d agoPREGABALIN — FDA approvalPREGABALIN

Sponsor: APOTEX. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →PREGABALIN →fda approvals ↗
›Feb 2, 2026approval190d agoMIRTAZAPINE — FDA approvalmirtazapine ODT

Sponsor: NOVITIUM PHARMA. Form: TABLET. Route: ORAL

full page →mirtazapine ODT →fda approvals ↗
›Feb 2, 2026approval190d agoESTRADIOL — FDA approvalLong Grove Pharmaceuticals LLC

Sponsor: LONG GROVE PHARMS. Form: GEL, METERED. Route: TRANSDERMAL

full page →fda approvals ↗
›Feb 2, 2026approval190d agoPREGABALIN — FDA approvalViatris Inc

Sponsor: CHANGZHOU PHARM. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗
›Feb 2, 2026device 510k190d agoNano-X Imaging , Ltd. — TAP2D (510k cleared)Nano-X Imaging Ltd.

Product code: IZF. Advisory committee: Radiology. Type: Traditional

full page →fda device 510k ↗
›Feb 2, 2026device 510k190d agoChengdu Besmile Medical Technology Co., Ltd. — BIORES Dental Implant System (510k cleared)

Product code: DZE. Advisory committee: Dental. Type: Abbreviated

full page →fda device 510k ↗
›Feb 2, 2026device 510k190d agoOxehealth Limited — Vital Signs (510k cleared)

Product code: QME. Advisory committee: Cardiovascular. Type: Traditional

full page →fda device 510k ↗
›Feb 2, 2026device 510k190d agoBeijing Kreate Medical Co., Ltd. — Redermax Antibacterial Wound Matrix (510k cleared)

Product code: FRO. Advisory committee: Unknown. Type: Traditional

full page →fda device 510k ↗
›Feb 2, 2026device 510k190d agoAsahi Intecc Co., Ltd. — CHIKAI Nexus petit (510k cleared)

Product code: MOF. Advisory committee: Cardiovascular. Type: Traditional

full page →fda device 510k ↗
›Feb 2, 2026device pma190d agoPhilips Medical Systems, Inc. — HeartStart OnSite Defibrillator (Model M5066A) and HeartStart Home Defibrillator (Model M5068A) (PMA supplement)MERIT MEDICAL SYSTEMS INC

Supplement type: 30-Day Notice. Product code: NSA. Advisory committee: CV. Decision: OK30

full page →fda device pma ↗
›Feb 2, 2026device pma190d agoCooperVision, Inc. — Biofmity XR Torie (comfilcon A) Soft (Hydrophilic) Contact Lenses for Extended Wear (PMA supplement)

Supplement type: 30-Day Notice. Product code: LPM. Advisory committee: OP. Decision: OK30

full page →fda device pma ↗
›Feb 2, 2026device pma190d agoEdwards Lifesciences, LLC — Edwards EVOQUE Tricuspid Valve Replacement System (PMA supplement)Edwards Lifesciences Corp

Supplement type: 30-Day Notice. Product code: NPW. Advisory committee: CV. Decision: OK30

full page →fda device pma ↗
›Feb 2, 2026device pma190d agoPhilips Medical Systems — HeartStart FRx Defibrillator (PMA supplement)

Supplement type: 30-Day Notice. Product code: MKJ. Advisory committee: CV. Decision: OK30

full page →fda device pma ↗
›Feb 2, 2026device recall190d agoB Braun Medical Inc device recall (Cls II)B. Braun Medical Inc

Brand Name: B. Braun Product Name: 21GA WINGED INF SET Model/Catalog Number: 7M2802 Software Version: N/A Product Description: A device designed for subcutaneous implantation and intended to be used temporarily to expand an implanted tissue expander by percutaneous injection of air or fluids. Component: N/A — Reason: The potential for the needle tip to be dull/blunt, difficult to advance, and/or break. — Status: Ongoing

full page →fda device recalls ↗
›Feb 2, 2026device recall190d agoHowmedica Osteonics Corp. device recall (Cls II)

MICS3 Angled Sagittal Saw Attachment; Part Number: 210490 — Reason: A potential issue was identified with the torque strength on the external screws of the MICS3 Angled Sagittal Saw Attachment. These screws, which secure the cover to the Angled Saw Housing, may loosen during use and detach from the attachment. — Status: Ongoing

full page →fda device recalls ↗
›Feb 2, 2026device recall190d agoB Braun Medical Inc device recall (Cls II)B. Braun Medical Inc

Brand Name: B. Braun Product Name: 21GA WINGED INFUSION, SINGLE PK Model/Catalog Number: 7A3842 Software Version: N/A Product Description: A device designed for subcutaneous implantation and intended to be used temporarily to expand an implanted tissue expander by percutaneous injection of air or fluids. Component: N/A — Reason: The potential for the needle tip to be dull/blunt, difficult to advance, and/or break. — Status: Ongoing

full page →fda device recalls ↗
›Feb 2, 2026device recall190d agoB Braun Medical Inc device recall (Cls II)B. Braun Medical Inc

Brand Name: B. Braun Product Name: BBraun Medical 21G X4.4CM Winged INF Model/Catalog Number: 7B3050 Software Version: N/A Product Description: A device designed for subcutaneous implantation and intended to be used temporarily to expand an implanted tissue expander by percutaneous injection of air or fluids. Component: N/A — Reason: The potential for the needle tip to be dull/blunt, difficult to advance, and/or break. — Status: Ongoing

full page →fda device recalls ↗
›Feb 2, 2026grant190d agoUNIVERSITY OF GEORGIA — Establishing a cystic fibrosis ferret model of chronic Mycobacterium abscessu...

AI grant. $224,857. PI: Tuhina Gupta

full page →nih reporter ↗
›Feb 2, 2026grant190d agoGEORGIA INSTITUTE OF TECHNOLOGY — Controlled Delivery of Adjuvanted Multivalent Fusion Peptide Focused HIV Vacc...

AI grant. $725,241. PI: M.G. Finn

full page →nih reporter ↗
›Feb 2, 2026grant190d agoHARVARD UNIVERSITY — Discovery of antimicrobial metabolites from the human gut microbiota using hi...

AI grant. $463,375. PI: Emily Patricia Balskus

full page →nih reporter ↗
›Feb 2, 2026grant190d agoEMORY UNIVERSITY — Inducible Hepatic-Associated Lymphoid Tissue (iHALT): generating and maintain...Emory University

AI grant. $922,840. PI: Arash Grakoui

full page →nih reporter ↗
›Feb 2, 2026grant190d agoSTATE UNIVERSITY NEW YORK STONY BROOK — Discrimination learning and neural dynamics in gustatory cortical circuits

DC grant. $638,908. PI: Alfredo Fontanini

full page →nih reporter ↗
›Feb 2, 2026grant190d agoWASHINGTON UNIVERSITY — Myelin and non-myelin immune responses in Multiple sclerosis

AI grant. $624,300. PI: Naresha Saligrama

full page →nih reporter ↗
›Feb 2, 2026grant190d agoEMORY UNIVERSITY — Investigating relationships between naturalistic light exposure and sleepEmory University

HL grant. $248,705. PI: Danielle A. Wallace

full page →nih reporter ↗
›Feb 2, 2026grant190d agoWASHINGTON UNIVERSITY — Sensing of viral infections in C. elegans

AI grant. $427,625. PI: DAVID WANG

full page →nih reporter ↗
›Feb 2, 2026grant190d agoOHIO STATE UNIVERSITY — Non-siderophore function of peroxisomes in Histoplasma pathogenesis

AI grant. $354,416. PI: Chad A Rappleye

full page →nih reporter ↗
›Feb 2, 2026grant190d agoLOUISIANA STATE UNIV A&M COL BATON ROUGE — Identification of RNAi-independent antiviral genes through biased genetic scr...

AI grant. $412,500. PI: Rui Lu

full page →nih reporter ↗
›Feb 2, 2026grant190d agoUNIVERSITY OF CALIFORNIA, SAN DIEGO — Assessing the longitudinal impact of Mediterranean diet interventions to redu...University of California San Diego

AG grant. $43,784. PI: Lucas Noah Patel

full page →nih reporter ↗
›Feb 2, 2026grant190d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — Reversing Graft Rejection by Targeting Innate Immune Memory with Novel Nanobi...

AI grant. $452,835. PI: Geoffrey Camirand

full page →nih reporter ↗
›Feb 2, 2026grant190d agoUNIVERSITY OF WISCONSIN-MADISON — The significant effects of butyrate on Clostridioides difficile fitness and p...

AI grant. $753,899. PI: Andrew John Hryckowian

full page →nih reporter ↗
›Feb 2, 2026grant190d agoUT SOUTHWESTERN MEDICAL CENTER — Oligoadenylate synthetase (OAS) in intestinal immunity

AI grant. $456,500. PI: Nan Yan

full page →nih reporter ↗
›Feb 2, 2026grant190d agoVIRGINIA POLYTECHNIC INST AND ST UNIV — Discovery and Development of antisense therapeutics for Clostridioides diffic...

AI grant. $437,541. PI: Mohamed Seleem

full page →nih reporter ↗
›Feb 2, 2026grant190d agoHARVARD MEDICAL SCHOOL — Elucidating the molecular and functional diversity of dorsal root ganglia som...

NS grant. $120,501. PI: Scott Andrew Shuster

full page →nih reporter ↗
›Feb 2, 2026grant190d agoUNIVERSITY OF CALIFORNIA, SAN DIEGO — Living Microrobot for Active Therapeutic Delivery to Treat Severe Pulmonary I...University of California San Diego

AI grant. $720,035. PI: Victor Nizet

full page →nih reporter ↗
›Feb 2, 2026grant190d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — Characterization of CD4 T cells targeting liver and blood stage malaria epitopesUniversity of California San Francisco

AI grant. $895,740. PI: MARGARET E FEENEY

full page →nih reporter ↗
›Feb 2, 2026grant190d agoUNIVERSITY OF CHICAGO — Intestinal Epithelial Heat Shock Protein 25/27 integrates host immune and mic...

DK grant. $770,995. PI: EUGENE B CHANG

full page →nih reporter ↗
›Feb 2, 2026grant190d agoUNIVERSITY OF FLORIDA — Renal and adrenal actions of the clock protein PER1 in salt-sensitive hyperte...University of Florida

DK grant. $663,104. PI: Michelle L Gumz

full page →nih reporter ↗
›Feb 2, 2026grant190d agoOREGON STATE UNIVERSITY — Biosynthesis of ureido containing natural products: Mechanistic studies and s...

AI grant. $495,688. PI: Benjamin Philmus

full page →nih reporter ↗
›Feb 2, 2026grant190d agoCOLUMBIA UNIVERSITY HEALTH SCIENCES — Targeted Depalmitoylation of Presynaptic CaV channels in Health and Disease

NS grant. $589,156. PI: Manu Ben Johny

full page →nih reporter ↗
← prev
page 1 of 2
next →
$VTRS16.39-0.21%
$EW91.33-2.47%
$MMSI90.30+1.42%
$NNOX1.7300+1.17%